Fat cell function and fibrinolysis
- PMID: 11246816
- DOI: 10.1055/s-2007-978677
Fat cell function and fibrinolysis
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is a specific inhibitor of plasminogen activators and may be the principal regulator of plasminogen activation in vivo. PAI-1 levels are elevated in insulin-resistant subjects and are associated with an increased risk of atherothrombosis. After adjustment for metabolic parameters, increased PAI-1 levels were no longer considered as a cardiovascular risk factor. The mechanisms underlying the strong association between PAI-1 levels and the metabolic disturbances found in insulin resistance are still not understood. Several studies have suggested that visceral adipose tissue may be a major source of PAl-1. Accordingly, adipose tissue PAI-1 production particularly that from visceral fat, was found to be elevated in obese human subjects. Within human adipose tissue, stromal cells appear to be the main cells involved in PAI-1 synthesis. This review discusses the potential mechanisms linking adipose tissue to plasma PAI-1 levels such as the intervention of cytokines (TNFalpha and TGFbeta), free fatty acids and hormones (insulin and glucocorticoids). Moreover alteration of adipose tissue cellular composition induced by the modulation of PAI-1 expression opens a novel field of interest.
Similar articles
-
Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.Ann Med. 2000 Dec;32 Suppl 1:78-84. Ann Med. 2000. PMID: 11209987 Review.
-
Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.Eur J Clin Invest. 2005 Sep;35(9):583-90. doi: 10.1111/j.1365-2362.2005.01547.x. Eur J Clin Invest. 2005. PMID: 16128865
-
[PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].Minerva Endocrinol. 2002 Sep;27(3):181-91. Minerva Endocrinol. 2002. PMID: 12091793 Review. Italian.
-
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. doi: 10.1038/sj.ijo.0802778. Int J Obes Relat Metab Disord. 2004. PMID: 15356668 Review.
-
PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.Thromb Haemost. 2008 Feb;99(2):352-6. doi: 10.1160/TH07-06-0395. Thromb Haemost. 2008. PMID: 18278185
Cited by
-
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.Nutr Metab (Lond). 2004 Nov 5;1(1):12. doi: 10.1186/1743-7075-1-12. Nutr Metab (Lond). 2004. PMID: 15530168 Free PMC article.
-
PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients.Int J Clin Exp Pathol. 2015 Dec 1;8(12):15919-25. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26884864 Free PMC article.
-
Advances in diabetes for the millennium: diabetes and the endothelium.MedGenMed. 2004 Sep 29;6(3 Suppl):6. MedGenMed. 2004. PMID: 15647711 Free PMC article. Review.
-
HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate.J Lipid Res. 2010 Sep;51(9):2619-28. doi: 10.1194/jlr.M003988. Epub 2010 Jun 3. J Lipid Res. 2010. PMID: 20522601 Free PMC article.
-
Coagulation and fibrinolysis abnormalities in obesity.J Endocrinol Invest. 2002 Nov;25(10):899-904. doi: 10.1007/BF03344054. J Endocrinol Invest. 2002. PMID: 12508953 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
